Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for treatment of hyperglycemia is seeing a dynamic landscape that has been shaped through the combination of changes in healthcare policies, scientific advancements and changing patient demographics. Market assessments indicate that the hyperglycemia treatment market is presently experiencing continuous growth due to the increasing cases of diabetes worldwide. Diabetes, which is associated with high blood sugar levels, affects people across the globe and as such demands effective treatments for hyperglycemia.
A notable development in this market is adopting leading edge therapies. Pharmaceutical companies are putting in place huge resources in research and development to avail new drugs that can treat hyperglycemia as well as its linkages with diabetes complications and origins. This trend manifests itself by the rise of modern insulin formulations, oral antidiabetics medications and advanced injectables thereby providing patients better choices towards more convenient and personalized treatment methods.
Moreover, there is currently an apparent inclination towards a patient-oriented approach to managing hyperglycaemia. Healthcare providers and pharmaceutical companies are increasingly working on products that can enable patients take medication at the right time. The innovations consist of painless or user friendly devices to administer insulin, wearable technologies for real-time glucose monitoring, digital health platforms allowing individual intervention in self-managing their condition among others. Patient engagement not only helps improve treatment outcomes but also ensures that care for diabetics is coordinated and integrated within a system.
Preventative health-care measures are another key factor shaping these market trends regarding diabetes management tools. Due to increased awareness on economic costs imposed by diabetic related complications efforts are being directed towards early diagnosis as well as pre-emptive approaches against advanced stages of Hyperglycemia resulting from type II diabetes (Nguyen 2015). As such diagnostic tools and screening techniques have become highly sought after devices capable of signaling prediabetes or diabetes before it goes full blown thus enabling early interventions by clinicians.
The regulatory environment including healthcare policies play important role in determining market dynamics. Governments and regulatory agencies across the world are undertaking initiatives aimed at combating the rise of diabetes, which involves fostering affordability and availability of low cost products for Hyperglycemia. These measures include streamlining drug approvals, incentivizing research and development within this sector as well as promoting generics so that they are affordable and accessible.
The market for hyperglycaemic treatments is not just limited to developed regions but also emerging economies. Rising urbanization, lack of exercise and dietary changes have led to high incidences of diabetes in these countries. In line with this, pharmaceuticals companies consider these markets strategic by adjusting their products to fit into local contexts, partnering with local healthcare providers while participating alongside other stakeholders in improving awareness about diabetes globally.
Hyperglycemia Treatment Market Highlights:
Global Hyperglycemia Treatment Market Overview
Hyperglycemia Treatment Market Size was valued at USD 0.65 Billion in 2023. The Global Hyperglycemia Treatment industry is projected to grow from USD 0.72 Billion in 2024 to USD 1.59 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.02% during the forecast period (2024 - 2032).
Hyperglycemia is an excess of glucose in the bloodstream, and is often associated with diabetes mellitus. It occurs when the body does not have enough insulin to control the sugar level or unable to produce the insulin. Furthermore, hyperglycemia if remains untreated may cause serious complications such as nerve damage or neuropathy, kidney damage, kidney failure, cardiovascular disease, eye disease, and skin problems such as bacterial and fungal infections. The major signs of hyperglycemia are polydipsia (a great thirst), polyuria (a need to urinate often), and a dry mouth.
Increasing prevalence of diabetes, and growing investment in biotechnology and pharmaceutical industries, and rising need for the better treatment methods drive the growth of the Hyperglycemia Treatment Market.
According to the WHO, the global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. Where as in 2015, 1.6 million deaths were caused due to diabetes. Another, 2.2 million deaths were attributed to high blood glucose level in 2012.
According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies across the globe. This is higher than the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.
Moreover, increasing awareness about diabetes care and management, and advancing technology in medical devices are adding fuel to the growth of the market. Furthermore, increasing prevalence of obesity and consumption of unhealthy diet also drive Hyperglycemia Treatment Market growth.
However, availability of expensive treatment and poor reimbursement policy are some of the factors, which may slow the Hyperglycemia Treatment Market growth during the forecast period.
Segmentations
The hyperglycemia treatment market is segmented on the basis of treatment, mode of administration, and end user.
On the basis of treatment, it is segmented into fluid replacement, electrolyte replacement, insulin therapy, and drugs. The drugs segment is further segmented into sulfonylureas, biguanides, thiazolidinediones, and others.
On the basis of mode of administration, it is segmented into topical, oral, and others.
On the basis of end user, the market is segmented into hospitals & clinics, retail pharmacy, and others
Regional Analysis
The Americas dominates the hyperglycemia treatment market owing to well-developed technology, increasing patient with diabetes, increasing prevalence of neurological disorders, increasing patient population of kidney failure caused by severe hyperglycemia, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the hyperglycemia treatment market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.
Asia Pacific is the fastest growing hyperglycemia treatment market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of the hyperglycemia treatment in the region.
On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa.
Key Players
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
